CC
CLB icon

Curian Capital’s Core Laboratories CLB Stock Holding History

Curian Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50,632
Closed -$5.05M – 491
2015
Q3 		$5.05M Sell
50,632
-21,092
-29% -$2.29M 0.13% 178
2015
Q2 		$8.18M Buy
71,724
+519
+0.7% +$62.9K 0.14% 191
2015
Q1 		$7.44M Buy
71,205
+3,900
+6% +$416K 0.12% 195
2014
Q4 		$8.1M Buy
+67,305
New +$8.84M 0.14% 180

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Curian Capital's CLB Position: Q4 2015 in Review

Curian Capital sold out of Core Laboratories (CLB) in Q4 2015, closing a stake of 50,632 shares — an estimated $5.05M sold.

Curian Capital first reported a position in CLB in Q4 2014 and held it in 4 quarters. The position peaked at $8.18M in Q2 2015. 371 funds tracked by Wall St. Rank hold CLB as of Q4 2015.

  • Curian Capital reported no remaining Core Laboratories position as of Q4 2015 after selling out during the quarter.
  • Curian Capital sold 50,632 Core Laboratories shares in Q4 2015, an estimated $5.05M.
  • Curian Capital first reported a position in Core Laboratories in Q4 2014 and held it in 4 quarters.
  • Curian Capital's Core Laboratories position peaked at $8.18M in Q2 2015.
  • 371 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2015.

Based on Curian Capital's 13F filing for Q4 2015, filed 25 Jan 2016.